Le Lézard
Classified in: Health
Subjects: AWD, TRI

2022 Sternfels Prize for Drug Safety Research Opens


IRVINE, Calif., Sept. 7, 2021 /PRNewswire/ -- The 2022 Sternfels Prize for Drug Safety Discoveries contest opened today. The Sternfels Prize recognizes and rewards research ideas to reduce the risks associated with the real-world use of prescription drugs.

The $35,000 Prize is awarded annually to the most novel, clinically relevant, and testable idea to reduce a life-threatening drug-drug, drug-disease, or pharmacogenomic interaction.

Now in its 6th year, the Contest was created to incentivize pharmacologists, pharmacists, medical practitioners, academics, and students to generate testable hypotheses that could explain why certain patients experience side effects due to polypharmacy, interacting co-morbidities, and genetics.

Judges of last year's Prize included Dr. David Greenblatt of Tufts University, Dr. Sara Van Driest from Vanderbilt University, and Dr. Mark Ratain of the University of Chicago.

"As scientific knowledge expands, the possibility of solving/preventing serious adverse events also expands. The Sternfels Prize stimulates and rewards this kind of thinking, and I am excited to be a part of it," Dr. Ratain said. Sundar Srinivasan, Chief Executive Officer of Emerald Lake Safety, the 2022 underwriter of the award said, "We are proud to underwrite this amazing contest. Everyone's a winner ? the top 30 entrants, every applicant who pushes their own thinking, and of course the future patients who can be steered out of harm's way."

In addition to the winning cash prize, the top 30 applicants will receive their choice of a free Apple® iPad or Watch for their efforts. Responses submitted before Dec. 15, 2021 will receive critical feedback and the opportunity to resubmit their application ahead of the closing deadline, Jan. 31, 2022.

Submissions remain the property of the applicant and/or their research institution and are kept confidential. For more information, visit www.sternfelsprize.org.

The Sternfels Prize is named in honor of Edith and Ernst Sternfels. Ernst was an engineer, who helped build chemical plants that created life-improving molecules. Edith was a nurse, dedicated to the welfare and treatment of patients. Together, they represent the breadth of modern medicine, from highly technical science to personal attention and care.

Press Contact:
Christina Chow
[email protected] 
(773) 357-5481

SOURCE The Sternfels Prize for Drug Safety Discoveries


These press releases may also interest you

at 01:00
In response to valuable feedback from our customers, Luraco Technologies is thrilled to announce the launch of an upgrade to our medical massage chair lineup. We are introducing the Luraco i9 Max Plus Series, a revolution of the i9 Max Series. The i9...

at 00:01
Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult patients...

16 mai 2024
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson for $850 million in cash,...

16 mai 2024
Seelos Therapeutics, Inc. ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system ("CNS") disorders and rare diseases, announced today that it has entered into a...

16 mai 2024
We are advised by Hidden River Eating Disorder Residential Treatment that journalists and other readers should disregard the news release, Hidden River Announces Insurance Contract with Blue Cross Blue Shield, issued 16-May-2024 over PR Newswire....

16 mai 2024
Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced the appointment of Mark S. de Jong, PhD, to the newly created position of Chief Technical Officer (CTO). Dr. de Jong, joins Full-Life with 43...



News published on and distributed by: